- Home
- CRBP vs DIBS Comparison
CRBP vs DIBS Comparison
Compare CRBP & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- DIBS
- Stock Information
- Founded
- CRBP 2009
- DIBS 2000
- Country
- CRBP United States
- DIBS United States
- Employees
- CRBP N/A
- DIBS N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- DIBS Catalog/Specialty Distribution
- Sector
- CRBP Health Care
- DIBS Consumer Discretionary
- Exchange
- CRBP Nasdaq
- DIBS Nasdaq
- Market Cap
- CRBP 73.4M
- DIBS 86.4M
- IPO Year
- CRBP N/A
- DIBS 2021
- Fundamental
- Price
- CRBP $6.45
- DIBS $2.66
- Analyst Decision
- CRBP Strong Buy
- DIBS Hold
- Analyst Count
- CRBP 10
- DIBS 1
- Target Price
- CRBP $53.56
- DIBS N/A
- AVG Volume (30 Days)
- CRBP 147.8K
- DIBS 124.6K
- Earning Date
- CRBP 05-06-2025
- DIBS 05-09-2025
- Dividend Yield
- CRBP N/A
- DIBS N/A
- EPS Growth
- CRBP N/A
- DIBS N/A
- EPS
- CRBP N/A
- DIBS N/A
- Revenue
- CRBP N/A
- DIBS $88,740,000.00
- Revenue This Year
- CRBP N/A
- DIBS $4.62
- Revenue Next Year
- CRBP $150.00
- DIBS $6.44
- P/E Ratio
- CRBP N/A
- DIBS N/A
- Revenue Growth
- CRBP N/A
- DIBS 4.22
- 52 Week Low
- CRBP $4.64
- DIBS $2.30
- 52 Week High
- CRBP $61.90
- DIBS $6.20
- Technical
- Relative Strength Index (RSI)
- CRBP 46.87
- DIBS 52.99
- Support Level
- CRBP $6.10
- DIBS $2.41
- Resistance Level
- CRBP $8.07
- DIBS $2.79
- Average True Range (ATR)
- CRBP 0.71
- DIBS 0.19
- MACD
- CRBP -0.10
- DIBS 0.05
- Stochastic Oscillator
- CRBP 13.31
- DIBS 69.05
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.